| 1st Jul 2019 7:00 am |
RNS |
Teplizumab Article |
| 28th Jun 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 28th Jun 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 28th Jun 2019 10:54 am |
RNS |
Change of Adviser |
| 25th Jun 2019 7:00 am |
RNS |
Director/PDMR Shareholding |
| 24th Jun 2019 7:00 am |
RNS |
Article on Clinical Activity of OKT3 |
| 11th Jun 2019 7:00 am |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2019 9:44 am |
RNS |
Director/PDMR Shareholding |
| 3rd Jun 2019 7:00 am |
RNS |
PDMR Dealings |
| 31st May 2019 11:05 am |
RNS |
Result of AGM |
| 28th May 2019 7:00 am |
RNS |
9th Annual LD Micro Invitational |
| 7th May 2019 7:00 am |
RNS |
Notice of AGM |
| 2nd May 2019 7:00 am |
RNS |
Director/PDMR Shareholding |
| 1st May 2019 7:00 am |
RNS |
Update on IND Application |
| 25th Apr 2019 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 24th Apr 2019 12:55 pm |
RNS |
Reissue: Interim Clinical Data |
| 24th Apr 2019 7:00 am |
RNS |
Interim Clinical Data |
| 15th Apr 2019 5:45 pm |
RNS |
Holding(s) in Company |
| 15th Apr 2019 5:45 pm |
RNS |
Holding(s) in Company |
| 15th Apr 2019 5:45 pm |
RNS |
Holding(s) in Company |
| 4th Apr 2019 7:00 am |
RNS |
Final Results |
| 20th Mar 2019 7:00 am |
RNS |
IND Application Submitted for NASH Oral Treatment |
| 7th Feb 2019 7:00 am |
RNS |
Directorate Change |
| 11th Dec 2018 7:00 am |
RNS |
Exercise of Warrants & Issue of Equity |
| 3rd Dec 2018 7:00 am |
RNS |
Milciclib HCC Phase IIa Trial Enrollment Completed |
| 28th Nov 2018 7:00 am |
RNS |
Foralumab: Phase 1 Trial with Nasal Administration |
| 27th Nov 2018 7:00 am |
RNS |
Holding(s) in Company |
| 26th Nov 2018 7:00 am |
RNS |
Statement re: ADSs |
| 23rd Nov 2018 5:00 pm |
RNS |
Closing of Offering and Total Voting Rights |
| 20th Nov 2018 7:30 am |
RNS |
Discounted exercise prices of outstanding warrants |
| 20th Nov 2018 7:00 am |
RNS |
Offer Pricing, Nasdaq Listing & Loan Conversion |
| 18th Oct 2018 7:15 am |
RNS |
Amended Registration Statement filed with the SEC |
| 16th Oct 2018 7:00 am |
RNS |
Milciclib synergistic activity presented at AASLD |
| 25th Sep 2018 7:00 am |
RNS |
Tiziana announces Offering & Application to Nasdaq |
| 24th Sep 2018 7:03 am |
RNS |
Interim Results for Six Months Ended 30 June 2018 |
| 24th Sep 2018 7:00 am |
RNS |
U.S. FDA Approval IND Nasal Foralumab Phase 1 |
| 13th Sep 2018 1:05 pm |
RNS |
PDMR Dealing |
| 12th Sep 2018 7:00 am |
RNS |
PDMR dealings |
| 11th Sep 2018 7:00 am |
RNS |
PDMR Dealing |
| 24th Aug 2018 7:00 am |
RNS |
PDMR Dealing |
